This event will explore the challenges in clinical trials for orphan drugs and rare diseases, bringing together clinical operations professionals from across multiple therapeutic areas to discuss common obstacles and solutions. We will explore the benefits of early planning and engagement with regulatory authorities, the importance of working closely with patients and patient advocacy groups, recruiting and retaining patients for rare disease studies, and much more.

Co-located with our brand new Clinical Data Management Innovation conference, we will have sessions specifically on data management within rare disease settings, how to make the most of limited data sets, and how real world evidence can support data for your rare disease and orphan drug clinical trials.